SCHEMBL23877253

SCHEMBL23877253

Cc1cc(=O)c2ccc(C(C)C)nc2o1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 8/20 0.36
KDR P35968 8/20 0.36
PDGFRB P09619 5/20 0.36
PDGFRA P16234 2/20 0.36
TBK1 Q9UHD2 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALDH1A1 P00352 4/20 0.35
GAA P10253 2/20 0.35
KDM4E B2RXH2 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 2/20 0.35
PTGS2 P35354 1/20 0.35
CYP1A1 P04798 1/20 0.35
CYP3A4 P08684 1/20 0.35
ADORA3 P0DMS8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26534233 0.80 NOS1 (0.43) EGFRKDRMEN1NPC1HTT
SCHEMBL26485086 0.78 EGFR (0.35) EGFRKDRPDGFRBPDGFRAMEN1
SCHEMBL23877251 0.73 KDM4E (0.36) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL18054845 0.71 ALDH1A1 (0.40) TBK1MEN1NPC1RAB9AKMT2A
SCHEMBL10507830 0.68 KDM4E (0.49) MEN1NPC1HTTRAB9AKMT2A
SCHEMBL20752018 0.68 MCL1 (0.38) MEN1NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL20751936 0.67 SMN1; SMN2 (0.40) TBK1MEN1NPC1HTTRAB9A
SCHEMBL20321522 0.67 ALDH1A1 (0.37) EGFRKDRMEN1NPC1HTT
SCHEMBL12929968 0.67 TNKS (0.48) TBK1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL20751959 0.67 CYP2A6 (0.36) MEN1HTTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021194914-A1 SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2021-09-30 WO disclosed